Prenatal diagnosis and carrier detection for molybdenum cofactor deficiency type A in northern Israel using polymorphic DNA markers
Some experts worry that broader use of certain peptides through compounding could lead to a large portion of patients being exposed to risks without clear long-term safety data
Cagrilintide Monotherapy (Representative Research Pattern): Cagrilintide in Combination Therapy (e.g., with Semaglutide - CagriSema): Trials investigating combinations like CagriSema use specific dose levels of each component, also typically involving escalation schedules for both peptides
Acta Biochim Biophys Sin 53:11891197
Raschell Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
Hepatology 32 , 1116 (2000)